Friday, April 19, 2024 4/19/2024

A brief motivational interviewing-based intervention to improve HIV pre-exposure prophylaxis uptake among men who have sex with men

Award Number: R34DA042648
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY Gay, bisexual and other men who have sex with men (MSM) are the group at highest risk of HIV infection in the United States. Pre-exposure prophylaxis (PrEP) has demonstrated high efficacy in preventing HIV infection among MSM. However, uptake in clinical settings has been slow for several reasons, including low awareness and education, low perceived HIV risk, concern for side-effects, and stigma associated with taking the medication. The purpose of the proposed study is to develop and evaluate a brief motivational interviewing (MI) intervention to promote PrEP uptake among MSM during the course of routine HIV screening at a public sexually transmitted disease (STD) clinic. The study will focus on MSM who are at highest risk of incident HIV infection including those who use illicit substances and report condomless sex. Qualitative interviews with HIV-negative, high-risk MSM who have not taken PrEP will inform the initial development of the intervention (Specific Aim 1). Interviews will explore individual- and structural-level facilitators and barriers to PrEP uptake as well as acceptable methods of delivering the intervention. The intervention will then be pilot tested among a small sample (n=15) of high-risk MSM at the public STD clinic (Specific Aim 2). The intervention will consist of a brief MI session, which will include acceptance-based techniques. The initial intervention will take place at the STD clinic (15 minutes), followed by a booster session when STD results are delivered by phone one week later (10 minutes). The intervention will be designed to be feasible and acceptable in a busy clinical setting. After refining the intervention, a small randomized controlled trial (RCT; n=100) will be conducted to assess the impact of the intervention on PrEP uptake relative to an education-only control condition (Specific Aim 3). The goal of the study will be to improve PrEP uptake among a group that is at highest risk of HIV infection. At baseline, one-, and three-month follow-up visits, sexual risk behaviors and substance use will be assessed. Outcomes of the study will include acceptability and feasibility of the intervention as well as preliminary efficacy of increasing PrEP uptake. To measure PrEP uptake, we will evaluate PrEP prescriptions, subsequent retention in care at follow-up visits, and adherence (by self-report and drug levels). The results of this study will inform development of a scalable, novel intervention to promote PrEP uptake among high-risk MSM and will provide the basis for a future R01 efficacy trial.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2022 ( Subtotal = -$489 )
2022	2019	THE MIRIAM HOSPITAL	164 SUMMIT AVE	PROVIDENCE	RI	02906	PROVIDENCE	USA	Drug Abuse and Addiction Research Programs	000	3	11/15/2021	NON-COMPETING CONTINUATION	-$489
														Subtotal = -$489

Issue Date FY: 2019 ( Subtotal = $227,406 )
2019	2019	THE MIRIAM HOSPITAL	164 SUMMIT AVE	PROVIDENCE	RI	02906	PROVIDENCE	USA	Drug Abuse and Addiction Research Programs	000	3	4/26/2019	NON-COMPETING CONTINUATION	$227,406
														Subtotal = $227,406

Issue Date FY: 2018 ( Subtotal = $227,159 )
2018	2018	THE MIRIAM HOSPITAL	164 SUMMIT AVE	PROVIDENCE	RI	02906	PROVIDENCE	USA	Drug Abuse and Addiction Research Programs	000	2	4/11/2018	NON-COMPETING CONTINUATION	$227,159
														Subtotal = $227,159

Issue Date FY: 2017 ( Subtotal = $237,746 )
2017	2017	THE MIRIAM HOSPITAL	164 SUMMIT AVE	PROVIDENCE	RI	02906	PROVIDENCE	USA	Drug Abuse and Addiction Research Programs	000	1	4/5/2017	NEW	$237,746
														Subtotal = $237,746

Grand Total All Awards = $691,822

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A brief motivational interviewing-based intervention to improve HIV pre-exposure prophylaxis uptake among men who have sex with men

Award Number: R34DA042648

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer